newsfilter
← Latest News
GlobeNewswire·

Prime Medicine to Host Virtual KOL Event to Showcase Wilson's Disease Strategy

CAMBRIDGE, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (NASDAQ:PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced